Where I see patients (1)
Selected research
-
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
The New England journal of medicine
-
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores.
Respiratory medicine
-
Clinical and Biological Features of a Thickened Basement Membrane Zone in Asthma.
American journal of respiratory and critical care medicine